Blog
About

1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.

      Journal of the European Academy of Dermatology and Venereology

      Adult, Aged, Aged, 80 and over, Clobetasol, analogs & derivatives, therapeutic use, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Hand Dermatoses, diagnosis, Treatment Outcome, drug therapy, Humans, Male, Middle Aged, Nails, drug effects, Prospective Studies, Psoriasis, Administration, Topical

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Treatment of nail psoriasis is difficult. Several topical therapies have been employed with poor results because drug penetration is limited in this localization. Recently, a new formulation containing 8% clobetasol-17-propionate in a colourless nail lacquer vehicle has shown good results in the control of nail psoriasis. To determine the efficacy and safety of 8% clobetasol-17-propionate in a lacquer vehicle in nail psoriasis. Ten patients with both nail bed and matrix psoriasis were included in the study. They were treated with a colourless nail lacquer containing 8% clobetasol-17-propionate that was applied once daily for 21 days and then twice weekly for 9 months. Within 4 weeks of therapy there was a reduction of all the nail alterations, including nail pain. Therapeutic response was directly related to the length of therapy. The nail parameters that responded best to therapy were onycholysis, pitting and salmon patches. Subungual hyperkeratosis and splinter haemorrhages on the other hand had moderate and poor improvement, respectively. The treatment was well tolerated in all of the patients and there were no local (i.e. atrophy and sobreinfection) or systemic secondary effects. The formulation containing 8% clobetasol-17-propionate is a safe, effective and cosmetically highly acceptable treatment for nail bed and matrix psoriasis.

          Related collections

          Author and article information

          Journal
          16164711
          10.1111/j.1468-3083.2005.01253.x

          Comments

          Comment on this article